Complications of cancer immunotherapy with levamisole (Q28318117)

2

0 references

L M Jerry

3

0 references

A Capek

4

0 references

H R Shibata

5

0 references

P W Mansell

6

0 references

M G Lewis

7

0 references

G Marquis

8

0 references

D. R. Parkinson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A68226

13 April 2022

P. O. Cano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A68226

13 April 2022

L. M. Jerry

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A68226

13 April 2022

A. Capek

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A68226

13 April 2022

H. R. Shibata

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A68226

13 April 2022

P. W. Mansell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A68226

13 April 2022

M. G. Lewis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A68226

13 April 2022

G. Marquis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A68226

full work available at URL

13 April 2022

language of work or name

English

0 references

publication date

28 May 1977

0 references

https://api.elsevier.com/content/article/PII:S0140673677923868?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(77)92386-8

https://api.elsevier.com/content/article/PII:S0140673677923868?httpAccept=text/plain

13 April 2022

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(77)92386-8

13 April 2022

0 references

1

0 references

page(s)

1129-32

0 references

issue

8022

0 references

cites work

Letter: Leucocytotoxic effect of levamisole

2

i

369

Rosenthal

1976

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(77)92386-8

Letter: Levamisole and agranulocytosis

13 April 2022

5

i

1080

Williams

1976

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(77)92386-8

Agranulocytosis due to levamisole

13 April 2022

8

ii

1248

Graber

1976

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(77)92386-8

Levamisole and agranolocytosis

13 April 2022

9

i

4 7

Clara

1977

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(77)92386-8

Studies on leucocyte iso- and auto-antibodies

13 April 2022

12

7

223

Engelfriet

1961

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(77)92386-8

C1q deviation test for the detection of immune complexes, aggregates of IgG, and bacterial products in human serum

13 April 2022

14

142

139

Sobel

1975

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(77)92386-8

A method of trace iodination of proteins for immunologic studies

13 April 2022

16

29

185

McConahey

1966

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(77)92386-8

Protein measurement with the Folin phenol reagent

13 April 2022

18

193

265

Lowry

1951

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(77)92386-8

Recurrent agranulocytosis after levamisole

13 April 2022

23

0 references

Identifiers